Excitatory/inhibitory imbalance in autism spectrum disorders

Implications for interventions and therapeutics

Genoveva Uzunova, Stefano Pallanti, Eric Hollander

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objectives: Imbalance between excitation and inhibition and increased excitatory-inhibitory (E-I) ratio is a common mechanism in autism spectrum disorders (ASD) that is responsible for the learning and memory, cognitive, sensory, motor deficits, and seizures occurring in these disorders. ASD are very heterogeneous and better understanding of E-I imbalance in brain will lead to better diagnosis and treatments. Methods: We perform a critical literature review of the causes and presentations of E-I imbalance in ASD. Results: E-I imbalance in ASD is due primarily to abnormal glutamatergic and GABAergic neurotransmission in key brain regions such as neocortex, hippocampus, amygdala, and cerebellum. Other causes are due to dysfunction of neuropeptides (oxytocin), synaptic proteins (neuroligins), and immune system molecules (cytokines). At the neuropathological level E-I imbalance in ASD is presented as a “minicolumnopathy”. E-I imbalance alters the manner by which the brain processes information and regulates behaviour. New developments for investigating E-I imbalance such as optogenetics and transcranial magnetic stimulation (TMS) are presented. Non-invasive brain stimulation methods such as TMS for treatment of the core symptoms of ASD are discussed. Conclusions: Understanding E-I imbalance has important implications for developing better pharmacological and behavioural treatments for ASD, including TMS, new drugs, biomarkers and patient stratification.

Original languageEnglish (US)
JournalWorld Journal of Biological Psychiatry
DOIs
StateAccepted/In press - Oct 14 2015

Fingerprint

Transcranial Magnetic Stimulation
Brain
Therapeutics
Optogenetics
Neocortex
Oxytocin
Autism Spectrum Disorder
Amygdala
Neuropeptides
Synaptic Transmission
Cerebellum
Immune System
Hippocampus
Seizures
Biomarkers
Learning
Pharmacology
Cytokines
Pharmaceutical Preparations
Proteins

Keywords

  • Autistic disorder
  • biomarkers
  • electroencephalography
  • transcranial magnetic stimulation
  • translational medical research

ASJC Scopus subject areas

  • Biological Psychiatry
  • Psychiatry and Mental health

Cite this

@article{aea6d6bc930442a6ba9fd9c29da0b596,
title = "Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics",
abstract = "Objectives: Imbalance between excitation and inhibition and increased excitatory-inhibitory (E-I) ratio is a common mechanism in autism spectrum disorders (ASD) that is responsible for the learning and memory, cognitive, sensory, motor deficits, and seizures occurring in these disorders. ASD are very heterogeneous and better understanding of E-I imbalance in brain will lead to better diagnosis and treatments. Methods: We perform a critical literature review of the causes and presentations of E-I imbalance in ASD. Results: E-I imbalance in ASD is due primarily to abnormal glutamatergic and GABAergic neurotransmission in key brain regions such as neocortex, hippocampus, amygdala, and cerebellum. Other causes are due to dysfunction of neuropeptides (oxytocin), synaptic proteins (neuroligins), and immune system molecules (cytokines). At the neuropathological level E-I imbalance in ASD is presented as a “minicolumnopathy”. E-I imbalance alters the manner by which the brain processes information and regulates behaviour. New developments for investigating E-I imbalance such as optogenetics and transcranial magnetic stimulation (TMS) are presented. Non-invasive brain stimulation methods such as TMS for treatment of the core symptoms of ASD are discussed. Conclusions: Understanding E-I imbalance has important implications for developing better pharmacological and behavioural treatments for ASD, including TMS, new drugs, biomarkers and patient stratification.",
keywords = "Autistic disorder, biomarkers, electroencephalography, transcranial magnetic stimulation, translational medical research",
author = "Genoveva Uzunova and Stefano Pallanti and Eric Hollander",
year = "2015",
month = "10",
day = "14",
doi = "10.3109/15622975.2015.1085597",
language = "English (US)",
journal = "World Journal of Biological Psychiatry",
issn = "1562-2975",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Excitatory/inhibitory imbalance in autism spectrum disorders

T2 - Implications for interventions and therapeutics

AU - Uzunova, Genoveva

AU - Pallanti, Stefano

AU - Hollander, Eric

PY - 2015/10/14

Y1 - 2015/10/14

N2 - Objectives: Imbalance between excitation and inhibition and increased excitatory-inhibitory (E-I) ratio is a common mechanism in autism spectrum disorders (ASD) that is responsible for the learning and memory, cognitive, sensory, motor deficits, and seizures occurring in these disorders. ASD are very heterogeneous and better understanding of E-I imbalance in brain will lead to better diagnosis and treatments. Methods: We perform a critical literature review of the causes and presentations of E-I imbalance in ASD. Results: E-I imbalance in ASD is due primarily to abnormal glutamatergic and GABAergic neurotransmission in key brain regions such as neocortex, hippocampus, amygdala, and cerebellum. Other causes are due to dysfunction of neuropeptides (oxytocin), synaptic proteins (neuroligins), and immune system molecules (cytokines). At the neuropathological level E-I imbalance in ASD is presented as a “minicolumnopathy”. E-I imbalance alters the manner by which the brain processes information and regulates behaviour. New developments for investigating E-I imbalance such as optogenetics and transcranial magnetic stimulation (TMS) are presented. Non-invasive brain stimulation methods such as TMS for treatment of the core symptoms of ASD are discussed. Conclusions: Understanding E-I imbalance has important implications for developing better pharmacological and behavioural treatments for ASD, including TMS, new drugs, biomarkers and patient stratification.

AB - Objectives: Imbalance between excitation and inhibition and increased excitatory-inhibitory (E-I) ratio is a common mechanism in autism spectrum disorders (ASD) that is responsible for the learning and memory, cognitive, sensory, motor deficits, and seizures occurring in these disorders. ASD are very heterogeneous and better understanding of E-I imbalance in brain will lead to better diagnosis and treatments. Methods: We perform a critical literature review of the causes and presentations of E-I imbalance in ASD. Results: E-I imbalance in ASD is due primarily to abnormal glutamatergic and GABAergic neurotransmission in key brain regions such as neocortex, hippocampus, amygdala, and cerebellum. Other causes are due to dysfunction of neuropeptides (oxytocin), synaptic proteins (neuroligins), and immune system molecules (cytokines). At the neuropathological level E-I imbalance in ASD is presented as a “minicolumnopathy”. E-I imbalance alters the manner by which the brain processes information and regulates behaviour. New developments for investigating E-I imbalance such as optogenetics and transcranial magnetic stimulation (TMS) are presented. Non-invasive brain stimulation methods such as TMS for treatment of the core symptoms of ASD are discussed. Conclusions: Understanding E-I imbalance has important implications for developing better pharmacological and behavioural treatments for ASD, including TMS, new drugs, biomarkers and patient stratification.

KW - Autistic disorder

KW - biomarkers

KW - electroencephalography

KW - transcranial magnetic stimulation

KW - translational medical research

UR - http://www.scopus.com/inward/record.url?scp=84945232126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945232126&partnerID=8YFLogxK

U2 - 10.3109/15622975.2015.1085597

DO - 10.3109/15622975.2015.1085597

M3 - Article

JO - World Journal of Biological Psychiatry

JF - World Journal of Biological Psychiatry

SN - 1562-2975

ER -